Healthcare 11 min

Healthcare M&A: How to Avoid Post-Deal Operational Failure

Healthcare M&A can look compelling on paper while concealing operational risks that emerge only after closing. Members of the Senior Executive Healthcare Think Tank explain why other factors deserve the same scrutiny as financial performance—and offer practical questions leaders should ask before the deal is done.

by Healthcare Editorial Team on September 15, 2026

Healthcare mergers and acquisitions are often built around a compelling financial or strategic thesis: expand market reach, add capabilities, improve scale or create efficiencies. Yet the hardest part of the transaction frequently begins after the paperwork is signed, when two organizations must actually function as one.

That issue often comes down to the way work actually happens. Employees develop workarounds. Physicians build relationships and routines that aren’t captured in organizational charts. Technology systems accumulate custom configurations. Data acquires its own definitions and dependencies. Products evolve along separate roadmaps. Leaders develop different approaches to decision-making and accountability. None of these realities necessarily makes an acquisition unattractive, but failing to understand them can make integration far more difficult than anticipated.

So what should healthcare leaders be looking for before they close the deal?

The members of the Senior Executive Healthcare Think Tank—a curated group of experts in healthcare operations, technology, workforce strategy, medical devices, data, AI and clinical systems—offer perspectives that collectively challenge the traditional due diligence checklist. The following insights explore where hidden operational risks tend to surface and, more importantly, the questions leaders should be asking while there is still time to act on the answers.

Start With the Technology Behind the Organization

For Jason Foodman, Managing Director at Archetype Growth, technology integration is one of the clearest examples of an operational risk that can be underestimated during diligence.

“One of the most challenging tasks after closing an M&A deal is integrating the respective organizations’ technology infrastructures,” Foodman says. “Most healthcare organizations rely on multiple specialized, often custom platforms and applications to handle everything from patient registration to provider licensure validation to claims management.”

That complexity makes a simple question—Which system should we keep?—insufficient. Leaders also need to understand what sits around each system, including people, workflows, integrations and institutional knowledge.

“Due diligence should include a detailed assessment of the technology platforms in use at the target organization,” he says. 

He notes that integrating disparate systems can be an enormous financial and operational burden for both organizations.

“The acquiring organization should develop a clear-eyed view of the costs of rearranging people, processes and operations to integrate technology infrastructures.”

Treat Culture as an Operational Asset

Eugene Zabolotsky, CEO of Health Helper, says culture can determine whether the strategic logic of a transaction survives contact with the organization.

“The most commonly overlooked operational issue in healthcare M&A is cultural integration,” Zabolotsky says. “Financial and strategic fit may look attractive, but value is lost when corporate cultures, work ethics, leadership styles and long-term goals are misaligned.”

That means cultural diligence should be concrete rather than subjective. Leaders should examine how decisions are made, how accountability works and how patients are treated—not simply whether executives describe the cultures as compatible.

“Due diligence must go beyond financials to evaluate how people work, make decisions, treat patients and execute,” he says.

In healthcare, he adds, integration is only successful “when culture, operations and long-term purpose move in the same direction.”

“Leaders spend significant time evaluating financial performance, technology, clinical capabilities and market opportunity, but often underestimate what happens when two organizations are suddenly asked to operate as one.”

Feri Naseh, Founder and CEO of MeTime Healing LLC

– Feri Naseh, Founder and CEO of MeTime Healing

SHARE IT

Know Who You Cannot Afford to Lose

Workforce integration is another risk that can remain invisible until it is too late, says Feri Naseh, Founder and CEO of MeTime Healing.

“Leaders spend significant time evaluating financial performance, technology, clinical capabilities and market opportunity, but often underestimate what happens when two organizations—with different cultures, leadership styles, workflows and employee expectations—are suddenly asked to operate as one,” Naseh says.

Her central diligence question is simple: Who might walk out the door?

“In healthcare, losing key clinicians or experienced staff can quickly become an operational and patient-care risk,” she says. Leaders should identify the employees they cannot afford to lose, understand what drives turnover and determine what institutional knowledge could disappear after closing.

“Workforce due diligence should receive the same rigor as financial and technology due diligence,” Naseh says. “Systems can be integrated quickly; trust, culture and institutional knowledge cannot.”

Reconcile Identity Before It Becomes a Revenue Problem

Tirumala Ashish Kumar Manne, Principal Cloud Architect at Optum, focuses on a less visible issue: whether the organizations actually agree on what their data represents.

“The most overlooked issue is identity and data reconciliation, not technology selection,” Manne says. “Diligence teams compare EHR platforms, billing systems and cloud contracts, but rarely ask whether patient identifiers, provider identifiers and diagnosis codes actually mean the same thing across both organizations.”

The consequences can emerge months after closing.

“That mismatch surfaces months after close as duplicate patient records, denied claims and providers missing from credentialing systems,” he says.

His diligence questions are therefore foundational: How does each organization define a patient, provider and encounter? Who owns the reconciliation when those definitions conflict?

Healthcare data experts have similarly warned that M&A can create duplicate records, restricted data access and costly redundancy when governance and data structures are not reconciled.

“Cultural fit gets attention because it is visible,” he says. “Data identity does not—until it starts generating denials and safety gaps.”

Test Relationships, Not Just Balance Sheets

Jacob Kupietzky, President of HealthCare Transformation (HCT), approaches M&A through the lens of organizational relationships.

“Culture is one of the hardest operational realities to assess on a financial statement—and one of the most consequential after an acquisition,” Kupietzky says.

He recommends looking beyond employee satisfaction scores to the quality of relationships.

“Leaders need to understand how the organization actually works together and the strength of its relationships with employees, physicians, patients and payors,” he says.

That means asking whether people trust leadership, whether physicians are engaged and whether the organization can attract and retain talent. It also means understanding how patients and external partners perceive the organization.

“A hospital can have an exceptional physical plant and strong financials, but if the relationships inside and around it are fractured, those challenges will be felt across the organization,” Kupietzky says.

“When an acquisition forces new systems or standardized policies without accounting for daily clinical routines, staff resort to manual workarounds.”

Mahendran Chinnaiah, Digital Healthcare Architect for a major U.S. healthcare and pharmacy services firm

– Mahendran Chinnaiah, Digital Healthcare Architect at a major U.S. healthcare and pharmacy services firm

SHARE IT

Find the Workarounds Before You Standardize

Mahendran Chinnaiah, Digital Healthcare Architect at a major U.S. healthcare and pharmacy services firm, notes that the official workflow is rarely the whole workflow.

“Front-line workflow friction and shadow data practices” are easily missed, Chinnaiah says. Leaders may carefully audit balance sheets and software licenses while overlooking how clinicians actually complete their work.

“When an acquisition forces new systems or standardized policies without accounting for daily clinical routines, staff resort to manual workarounds,” he says. “The result is rapid burnout, corrupted reporting and quiet turnover among essential providers.”

His diligence questions get directly into the work: What manual workarounds or shadow spreadsheets are staff using? How different are clinical habits and terminology? Where would patient handoffs break if systems changed immediately?

Research on health IT interoperability has found that poor information transfer can increase workload and require manual data entry—exactly the type of friction Chinnaiah says leaders should identify before integration.

Ask What Breaks on Day One

Asaad Hakeem of SARC MedIQ focuses on workflow compatibility.

“The most overlooked issue is workflow compatibility,” Hakeem says. “Two organizations can look complementary financially yet operate very differently.”

That difference can undermine the very synergies that justified the deal.

His preferred diligence question is deliberately blunt: “What breaks on day one if we combine these organizations?”

Leaders should map clinical workflows, systems, staffing, incentives and decision rights before they assign value to projected synergies.

The approach also reflects a broader lesson from healthcare integration research: Technology alone does not guarantee successful operational handoffs.

Make the Product Roadmap Part of Diligence

Rajani Kumar Sindavalam, Systems Engineering Leader at HCL America Inc., says buyers should examine whether acquired products genuinely strengthen the existing roadmap.

“The most overlooked parameter in healthcare M&A is how an acquired portfolio fits into the existing roadmap and whether products genuinely complement each other,” Sindavalam says.

Functional overlap can look like synergy but become a source of internal conflict, engineering duplication and confused market messaging.

“True synergy requires assets that fill explicit feature gaps or streamline workflows together,” he says.

He also urges leaders to investigate product reliability and field performance before closing.

“Superficial due diligence misses latent quality risks, leaving buyers facing unexpected FDA Form 483 citations or complaint spikes post-acquisition,” Sindavalam says.

For healthcare technology and medical-device acquisitions, therefore, the diligence checklist should extend from strategic fit to quality-system health, complaint history, field performance and the real cost of integration.

Build Guardrails Around Synergy

Sriharsha Chavali, Engineering Lead at a leading national dental services organization, shares concern that the word “synergy” can become an excuse for standardization without sufficient operational testing.

“One of the most underestimated risks in healthcare M&A is assuming synergy inherently produces improvement,” Chavali says.

He points out that enterprise standards can perform very differently at the local level, particularly across technology, data, revenue cycle and multi-facility operations.

“Consolidating teams, centralizing scheduling or standardizing systems may create financial value, but they can also disrupt workflows, reduce access, increase clinician burden and compromise continuity of care,” he says.

His answer is not to reject standardization but to put guardrails around it.

“The goal is not synergy at any cost, but synergy with guardrails,” Chavali says. “Engage frontline leaders early, sequence integration deliberately and measure success beyond savings through patient safety, access, workforce sustainability and operational reliability.”

Put Someone in Charge of Integration

Mark Francis, Founder and CEO of CaregiverZone, Inc., argues that even when leaders identify the right operational risks, integration can still falter without clear ownership.

“The most commonly overlooked operational issue in healthcare M&A is the most common operational issue for any M&A: gaining alignment on people, processes, comp systems, reporting lines, merged leadership, technologies and culture,” he says.

His solution is structural.

“Both the acquirer and acquiree should designate an Integration Leader—reporting to the CEO—responsible for post-deal performance,” Francis says.

That leader should have measurable milestones rather than an open-ended mandate.

“Both individuals should have a clear, quantified set of cross-functional performance metrics to be evaluated at 30, 90, 180 and 365 days,” he says. “Such dedicated attention to operations, integration and alignment signals to all stakeholders the critical importance of alignment and the urgency to prioritize actions related to operate efficiency as one entity.”

“The most overlooked issue in healthcare M&A is the gap between how work is done on paper and how it actually happens in daily operations.”

Vikas Gupta, Technical Manager for HCL Tech

– Vikas Gupta, Technical Manager at HCL America Inc.

SHARE IT

Discover Institutional Knowledge Before It Disappears

Vikas Gupta, Technical Manager at HCL America Inc., focuses on the gap between formal processes and actual operations.

“The most overlooked issue in healthcare M&A is the gap between how work is done on paper and how it actually happens in daily operations,” Gupta says.

That gap can exist in clinical workflows, referrals, scheduling and technology usage. It can also live inside individual employees who know how to navigate exceptions that never appear in formal documentation.

Gupta recommends asking: “Which critical processes depend on local workarounds, custom configurations or institutional knowledge?”

Those dependencies can become major barriers to integration and adoption, particularly when an acquirer assumes that a documented process accurately describes the real-world workflow.

A Better Approach to Healthcare M&A Due Diligence

  • Put technology architecture under the microscope. Specialized platforms and custom applications can make integration far more expensive than the deal model suggests.
  • Test cultural compatibility before signing. Leaders should compare standards, accountability, work styles, decision-making and long-term purpose.
  • Identify the people and knowledge that cannot be replaced. Determine which clinicians and experienced employees are essential and what could leave with them.
  • Reconcile data definitions early. Leaders should establish how both organizations define patients, providers and encounters before systems are merged.
  • Diligence relationships as carefully as assets. Examine trust in leadership, physician engagement, retention and relationships with patients and partners.
  • Expose shadow workflows. Leaders should identify manual workarounds, spreadsheets and other informal processes before forcing standardization.
  • Ask what breaks on day one. Mapp workflows, staffing, systems, incentives and decision rights before assigning value to synergies.
  • Evaluate product and quality-system fit. Buyers should examine roadmap alignment, reliability, complaint history and regulatory exposure.
  • Put guardrails around synergy. Measure integration by patient safety, access, workforce sustainability and operational reliability—not savings alone.
  • Give integration one accountable executive owner. Have an Integration Leader with CEO-level visibility and measurable 30-, 90-, 180- and 365-day goals.
  • Document how work really gets done. Leaders need to find local workarounds, custom configurations and institutional knowledge before those dependencies become integration barriers.

Turning Due Diligence Into Integration Success

Healthcare M&A succeeds or fails in the space between strategy and execution. Technology, workforce, culture, data and workflows are not separate integration workstreams—they are interdependent parts of the operating model.

The best diligence, therefore, asks questions that financial models cannot answer: Who will leave? What will break? Which definitions conflict? Where are the workarounds? What does the frontline know that the executive team does not? And who will own the integration when the transaction is complete?

As healthcare organizations pursue greater scale, those questions will become increasingly important. The strongest M&A strategies will not simply identify attractive assets; they will understand how those assets actually operate, how they connect and what must be protected before integration begins.


Copied to clipboard.